The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Viscosupplementation Treatment For Arthritis Market Across 2026–2030?
The viscosupplementation treatment for arthritis market has demonstrated robust expansion in recent times. This market is projected to expand from $4.18 billion in 2025 to $4.5 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.7%. Historically, this growth has stemmed from factors such as the increasing incidence of osteoarthritis, an expanding elderly demographic, the early uptake of hyaluronic acid injections in clinical settings, the proliferation of orthopedic treatment methodologies, and the accessibility of injectable treatments for joints.
The viscosupplementation treatment for arthritis market is projected to experience substantial growth in the upcoming years. By 2030, this market is anticipated to reach a size of $5.98 billion, expanding at a compound annual growth rate (CAGR) of 7.4%. This expansion during the forecast period is driven by several factors, including a rising demand for non-surgical arthritis interventions, increased healthcare spending on musculoskeletal conditions, the broadening availability of outpatient orthopedic services, a greater emphasis on enhancing quality of life, and continuous advancements in viscosupplement formulations. Key trends identified for the forecast period encompass the increasing embrace of single-injection treatment protocols, a heightened need for solutions offering prolonged pain relief, the proliferation of minimally invasive arthritis therapies, a stronger focus on developing better joint lubrication formulations, and an elevated commitment to patient-centered treatment methodologies.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30433&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Viscosupplementation Treatment For Arthritis Market?
The expanding occurrence of osteoarthritis is anticipated to fuel the growth of the viscosupplementation treatment for arthritis market in the coming years. Osteoarthritis is defined as a persistent joint condition marked by the progressive breakdown of cartilage, which results in discomfort, rigidity, and limited movement. The rising incidence of osteoarthritis is largely attributed to an aging demographic, given that the natural deterioration of joints over time renders older individuals more prone to this condition. Viscosupplementation therapy for arthritis aids in managing osteoarthritis by reinstating joint lubrication, alleviating discomfort, and enhancing mobility. For example, in February 2025, Springer Nature Group, a UK-based academic and professional publishing firm, projected knee osteoarthritis cases to be 12.94 million among males and 18.80 million among females. These numbers are expected to climb to 18.45 million for males and 25.60 million for females by 2046. Consequently, the escalating occurrence of osteoarthritis is propelling the expansion of the viscosupplementation treatment for arthritis market.
What Segmentation Levels Are Considered In The Viscosupplementation Treatment For Arthritis Market?
The viscosupplementation treatment for arthritis market covered in this report is segmented –
1) By Product Type: Single Injection, Three Injections, Five Injections
2) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Shoulder Osteoarthritis, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Other End-Users
Subsegments:
1) By Single Injection: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid
2) By Three Injections: Standard Hyaluronic Acid, Buffered Hyaluronic Acid, Biofermented Hyaluronic Acid
3) By Five Injections: Cross-Linked High Viscosity Hyaluronic Acid, Extended-Release Hyaluronic Acid, Multi-Dose Hyaluronic Acid
How Are Trends Shaping The Direction Of The Viscosupplementation Treatment For Arthritis Market?
Leading companies in the viscosupplementation treatment for the arthritis market are concentrating on developing innovative solutions, such as advanced hyaluronic acid formulations, aimed at improving joint lubrication, reducing pain, and enhancing mobility. These advanced hyaluronic acid formulations are specially engineered versions of hyaluronic acid, featuring enhanced molecular structure and viscosity, intended to provide more enduring joint lubrication and more effective pain management in arthritis treatment. For example, in February 2024, IBSA Group, a pharmaceutical company based in Switzerland, introduced its SINOVIAL range, a next-generation viscosupplementation treatment for musculoskeletal conditions. This range utilizes advanced NAHYCO technology, which blends high and low molecular weight hyaluronic acid to deliver efficient joint lubrication and extended pain relief. Engineered to mimic the functions of natural synovial fluid, these treatments bolster joint cushioning and shock absorption. The injectable formulation offers optimal viscosity and excellent tolerance, thereby supporting enhanced patient comfort, mobility, and the management of osteoarthritis and other musculoskeletal disorders.
Which Leading Firms Are Contributing To The Growth Of The Viscosupplementation Treatment For Arthritis Market?
Major companies operating in the viscosupplementation treatment for arthritis market are Johnson And Johnson, Sanofi S.A., LG Chem Ltd., Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co. Ltd., Zimmer Biomet Holdings Inc., IBSA Group, Bioventus Inc., Fidia Farmaceutici S.p.A., Ferring Pharmaceuticals A/S, Anika Therapeutics Inc., TRB Chemedica International S.A., Laboratoires VIVACY, Seikagaku Corporation, Regen Lab SA, Genzyme Corporation, Medtronic PLC, Orthogenix Inc., Hyundai Pharm Co. Ltd., DePuy Synthes
Read the full viscosupplementation treatment for arthritis market report here:
Which Regions Are Projected To Dominate The Viscosupplementation Treatment For Arthritis Market In The Coming Years?
North America was the largest region in the viscosupplementation treatment for arthritis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viscosupplementation treatment for arthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Viscosupplementation Treatment For Arthritis Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=30433&type=smp
Browse Through More Reports Similar to the Global Viscosupplementation Treatment For Arthritis Market 2026, By The Business Research Company
Rheumatology Therapeutics Global Market Report
https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report
Canine Arthritis Treatment Global Market Report
https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report
Rheumatoid Arthritis Drugs Global Market Report
https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model